Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

interferon alfa-2a (Roferon-A)

interferon alfa-2a is an FDA-licensed reference biologic from Hoffmann-La Roche Inc..

351(a) biologicBLA 103145 Hoffmann-La Roche Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
1986

Reference product

Originator biologic
351(a)BLA 103145

Roferon-A interferon alfa-2a

Hoffmann-La Roche Inc.

View full reference-product record
Approved
Marketing
Disc
Center
CDER
Patents
None listed

Molecular structure

RCSB Protein Data Bank

Experimental 3D structure for interferon alfa-2a from the RCSB Protein Data Bank (PDB 1ITF).

3D molecular structure of interferon alfa-2a (PDB entry 1ITF)

Interactive biological assembly from PDB entry 1ITF. Drag to rotate, scroll to zoom, and inspect the full atomic structure right here, with no need to leave the page.

Exclusivity & patent cliffs

Protection horizon
  1. Reference approval

    Approval date of the reference interferon alfa-2a product.

    40 yr 10 mo ago

interferon alfa-2a: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for interferon alfa-2a.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.